Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| UNCST Folio Number: HS576ES | Other Identifier | UNCST( Uganda National Council for Science & Technology) | |
| HDREC #REC Ref: 2019-083 | Other Identifier | School of Medicine,Higher Degrees Research Ethics Committee |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Infectious Diseases Institute, Uganda | OTHER |
Not provided
Not provided
Not provided
Not provided
Study purpose: To assess effect of mHealth Call for life Uganda tool (CFLU) on ART adherence among youth measured by interactive voice response to daily adherence calls mapped in the database and proportion with viral suppression of copies below 1000 copies/mL.
The intervention call for life Uganda (CFLU) uses IVR calls or text messages delivered via MOTECH™ based Connect for Life technology™. The calls are delivered in 4 languages (Luganda, English, Luo and Runyakitara) and the participant has to make a choice of the preferred language during registration to the system. The system offers adherence pill reminders, health message tips, visit appointment reminders and receipt of self-reported symptoms.
The intervention is mobile phone based IVR. However, the CLFU trial found that, it was observed that a good number of participants (50 of 256) at the urban site were not enrolled due to absence of a basic mobile phone, or had malfunctioning phone keyboards (for Poster Exhibition at the 20th International Conference on AIDS and STIs in Africa (ICASA 2019). Therefore, we shall provide a basic mobile phone to everyone in the study (SoC and intervention arm). To avoid stigma associated with a particular phone, we shall get 4 or more types of basic phones. Issues regarding simcard registration will be dealt with by the individuals.
Four study questionnaires will be administered at baseline and 6-monthly until the 12-month exit visit.
The questionnaires will capture:
Intervention: mHealth CFLU tool The tool capitalises on a basic mobile phone's core utilities of voice and short messaging services. The system design, development, testing and evaluation was done by Janssen and the Grameen Foundation (http://motechsuite.org/index.php/implementations). In 2015, Janssen Global Public Health Research and Development, in close collaboration with the Infectious Diseases Institute Kampala (IDI), developed Call for Life Uganda (CFLU) tailored to the needs of PLHIV in Uganda. The CFLU system follows the Health Insurance Portability and Accountability Act (HIPAA) Privacy and Security rules. While the Privacy rules deals with electronic Protected Health Information, the security rule covers administrative, physical and technical safeguards to ensure confidentiality, integrity and security of electronic protected health information. Data transaction between patient and system is encrypted when it comes to human subjects. The system is password protected, and interaction of system and patient is personalised with a secret code. The system interacts with the patient through a basic mobile phone via a keypad and with the health worker through a web-based interface. The system has options to either use interactive voice response or short message service and the user has to make a choice, get a secret pin code which ensures privacy to enduser.
Screening-Enrolment procedures:
All potential participants will be written on the screening log, and a screening form completed, reasons for screen failure will be documented on the screening log. Following successful screening, the participant will be referred to the Research Assistant (RA) to receive a thorough explanation of the study so and informed consent is obtained. The RA then administers the stigma questionnaire along with the sociodemographic and medical information, , HIV knowledge and sexual behaviour questionnaires. A client locater form will be completed which will help in physical contact tracing, and the participant will be registered on the enrolment log.
Randomisation will follow (see details of randomisation procedure below) thereafter and the result in the sealed envelope will dictate whether the patient will be registered onto the Call for Life System for the intervention or continue with standard of care as per Ministry of Health HIV Management guidelines.
Registration onto the CFLU system: Refer to Standard operating procedures on registration.
However, all patients will be registered onto the electronic and hard copy of the enrolment log and a next appointment date is given to them. Finally, the lab request forms are filled and the patient sent for a blood draw. The patient returns from the lab, receives their transport refund of UGX 20,000, with a basic mobile phone (only at baseline visit, to all participants) and is allowed to go home.
No intervention: Standard of care arm The Ministry of Health developed a minimum healthcare services package for PLHIV to standardize the programming, implementation and delivery of integrated HIV services in Uganda The standard of care arm is based on the Apr 2018, consolidated guidelines for prevention and treatment of HIV in Uganda (MoH, 2018), and will also follow the healthcare services package for PLHIV (Uganda. MoH, September 2014).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| intervention " Call for life- mHealth tool" with standard of care for PLHIV | Experimental | The system has options to either use interactive voice response or short message service and the user has to make a choice, get a secret pin code which ensures privacy to end user. The mHealth tool/system offers personalised pill reminder calls, health tip messages, clinic appointment reminders and remote symptom reporting |
|
| Standard of care "usual care" | No Intervention | Standard • Care and support for people living with HIV, and the first line ART regimen is based on the Apr 2018, consolidated guidelines for prevention and treatment of HIV in Uganda (MoH, 2018), and will also follow the healthcare services package for PLHIV including the Adult Care and Treatment Package. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| mHealth call for life system/ tool using IVR ( interactive voice response) | Other | The tool capitalises on a basic mobile phone's core utilities of voice and short messaging services. The system design, development, testing and evaluation was done by Janssen and the Grameen Foundation (http://motechsuite.org/index.php/implementations). In 2015, Janssen Global Public Health Research and Development, in close collaboration with the Infectious Diseases Institute Kampala (IDI), developed Call for Life Uganda (CFLU) tailored to the needs of PLHIV in Uganda |
| Measure | Description | Time Frame |
|---|---|---|
| • Viral Load Suppression | Viral load suppression as per Blood draws at 6 months for those on intervention and those on standard of care arm will be used to measure viral load at these time points | • Viral load suppression at 6 months |
| • Viral Load Suppression | Viral load suppression as per Blood draws at 12 months for those on intervention and those on standard of care arm will be used to measure viral load status at these time points | • Viral load suppression at 12 months |
| Proportions Retained in Care | Proportions of youth retained in care at 12 months for those on intervention in comparison to those on standard of care arm | 12 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Agnes B Naggirinya, MMed | Infectious Diseases Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kiryandongo | Kiryandongo | 256 | Uganda |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41121172 | Derived | Naggirinya AB, Rujumba J, Beinomugisha J, Nakazzi S, Waiswa P, Meya DB, Parkes-Ratanshi R. Brief communication: qualitative evaluation of call-for-life mHealth tool among youth living with HIV in Uganda. AIDS Res Ther. 2025 Oct 21;22(1):107. doi: 10.1186/s12981-025-00798-6. | |
| 39561129 | Derived | Bwanika Naggirinya A, Meya DB, Nabaggala MS, Banturaki G, Kiragga A, Rujumba J, Waiswa P, Parkes-Ratanshi R. Effectiveness of interactive voice response-call for life mHealth tool on adherence to anti-retroviral therapy among young people living with HIV: A randomized trial in Uganda. PLoS One. 2024 Nov 19;19(11):e0308923. doi: 10.1371/journal.pone.0308923. eCollection 2024. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The participants must have registered in either of the three study site. They should have been between 15-24 years and on ART for 6 months or less.
Recruitment started on 12th Aug 2020. Reccruitment was from three HIV/ART clinics in Kiryandongo District
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Intervention " Call for Life- mHealth Tool" With Standard of Care for PLHIV | The system has options to either use interactive voice response or short message service and the user has to make a choice, get a secret pin code which ensures privacy to end user. The mHealth tool/system offers personalised pill reminder calls, health tip messages, clinic appointment reminders and remote symptom reporting mHealth call for life system/ tool using IVR ( interactive voice response): The tool capitalises on a basic mobile phone's core utilities of voice and short messaging services. The system design, development, testing and evaluation was done by Janssen and the Grameen Foundation (http://motechsuite.org/index.php/implementations). In 2015, Janssen Global Public Health Research and Development, in close collaboration with the Infectious Diseases Institute Kampala (IDI), developed Call for Life Uganda (CFLU) tailored to the needs of PLHIV in Uganda |
| FG001 | Standard of Care "Usual Care" | Standard • Care and support for people living with HIV, and the first line ART regimen is based on the Apr 2018, consolidated guidelines for prevention and treatment of HIV in Uganda (MoH, 2018), and will also follow the healthcare services package for PLHIV including the Adult Care and Treatment Package. |
| Title | Milestones | Reasons Not Completed | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Young people 15-24 years initiating or on ART since 2019.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Intervention " Call for Life- mHealth Tool" With Standard of Care for PLHIV | The system has options to either use interactive voice response or short message service and the user has to make a choice, get a secret pin code which ensures privacy to end user. The mHealth tool/system offers personalised pill reminder calls, health tip messages, clinic appointment reminders and remote symptom reporting mHealth call for life system/ tool using IVR ( interactive voice response): The tool capitalises on a basic mobile phone's core utilities of voice and short messaging services. The system design, development, testing and evaluation was done by Janssen and the Grameen Foundation (http://motechsuite.org/index.php/implementations). In 2015, Janssen Global Public Health Research and Development, in close collaboration with the Infectious Diseases Institute Kampala (IDI), developed Call for Life Uganda (CFLU) tailored to the needs of PLHIV in Uganda |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | • Viral Load Suppression | Viral load suppression as per Blood draws at 6 months for those on intervention and those on standard of care arm will be used to measure viral load at these time points | Posted | Count of Participants | Participants | • Viral load suppression at 6 months |
|
Adverse event data were collected from participant randomization until exit. This period was 1year and 9 months.
ICH E6 Section 1.2. 5. • An adverse event can be any unfavorable and unintended sign, symptom, or disease that occurs to a study participant, even if not related to the intervention under study.
An AE becomes serious if it results into: Death. A life-threatening adverse event. Inpatient hospitalization, or prolonged of existing hospitalization. A persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions. A congenital anomaly/birth defect.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Intervention " Call for Life- mHealth Tool" With Standard of Care for PLHIV | The system has options to either use interactive voice response or short message service and the user has to make a choice, get a secret pin code which ensures privacy to end user. The mHealth tool/system offers personalised pill reminder calls, health tip messages, clinic appointment reminders and remote symptom reporting mHealth call for life system/ tool using IVR ( interactive voice response): The tool capitalises on a basic mobile phone's core utilities of voice and short messaging services. The system design, development, testing and evaluation was done by Janssen and the Grameen Foundation (http://motechsuite.org/index.php/implementations). In 2015, Janssen Global Public Health Research and Development, in close collaboration with the Infectious Diseases Institute Kampala (IDI), developed Call for Life Uganda (CFLU) tailored to the needs of PLHIV in Uganda |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Death | Infections and infestations | Non-systematic Assessment |
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr. Agnes Bwanika Naggirinya | Infectious Diseases Institute, College of Health Sciences, Makerere University | +256752521570 | anaggirinya@idi.co.ug |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP_ICF | Yes | Yes | Yes | Study Protocol, Statistical Analysis Plan, and Informed Consent Form | Jan 12, 2022 | Aug 2, 2022 | Prot_SAP_ICF_000.pdf |
Not provided
| ID | Term |
|---|---|
| D019002 | CD56 Antigen |
| ID | Term |
|---|---|
| D019006 | Neural Cell Adhesion Molecules |
| D015816 | Cell Adhesion Molecules, Neuronal |
| D015815 | Cell Adhesion Molecules |
| D008562 | Membrane Glycoproteins |
Not provided
Not provided
2 groups one on intervention of Call for life mHealth with standard of care and other on standard of care only.
mHealth Call for life Tool using interactive voice response
Not provided
Not provided
Not provided
Not provided
|
|
| Transferred out |
|
| BG001 | Standard of Care "Usual Care" | Standard • Care and support for people living with HIV, and the first line ART regimen is based on the Apr 2018, consolidated guidelines for prevention and treatment of HIV in Uganda (MoH, 2018), and will also follow the healthcare services package for PLHIV including the Adult Care and Treatment Package. |
| BG002 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | All participants were from the Black African Race | Count of Participants | Participants |
|
| Region of Enrollment | All participants were recruited from Kiryandongo district, North-Western Uganda region | Count of Participants | Participants |
|
| Viral load detection at baseline | Count of Participants | Participants |
|
| OG001 | Standard of Care "Usual Care" | Standard • Care and support for people living with HIV, and the first line ART regimen is based on the Apr 2018, consolidated guidelines for prevention and treatment of HIV in Uganda (MoH, 2018), and will also follow the healthcare services package for PLHIV including the Adult Care and Treatment Package. |
|
|
| Primary | • Viral Load Suppression | Viral load suppression as per Blood draws at 12 months for those on intervention and those on standard of care arm will be used to measure viral load status at these time points | Posted | Count of Participants | Participants | • Viral load suppression at 12 months |
|
|
|
| Primary | Proportions Retained in Care | Proportions of youth retained in care at 12 months for those on intervention in comparison to those on standard of care arm | Posted | Count of Participants | Participants | 12 months |
|
|
|
| 0 |
| 103 |
| 1 |
| 103 |
| 0 |
| 103 |
| EG001 | Standard of Care "Usual Care" | Standard • Care and support for people living with HIV, and the first line ART regimen is based on the Apr 2018, consolidated guidelines for prevention and treatment of HIV in Uganda (MoH, 2018), and will also follow the healthcare services package for PLHIV including the Adult Care and Treatment Package. | 2 | 103 | 2 | 103 | 0 | 103 |
| Road traffic Accident | Musculoskeletal and connective tissue disorders | Non-systematic Assessment | Participant was knocked while riding on a motorcycle |
|
Not provided
Not provided
| D006023 | Glycoproteins |
| D006001 | Glycoconjugates |
| D002241 | Carbohydrates |
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |
| D008565 | Membrane Proteins |
| D000945 | Antigens, Differentiation, T-Lymphocyte |
| D000943 | Antigens, Differentiation |
| D000954 | Antigens, Surface |
| D000941 | Antigens |
| D001685 | Biological Factors |
| D015415 | Biomarkers |